SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-001225
Filing Date
2015-02-17
Accepted
2015-02-17 16:21:35
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctxr_10q.htm 10-Q 181381
2 CERTIFICATION ctxr_ex311.htm EX-31.1 8326
3 CERTIFICATION ctxr_ex321.htm EX-32 3107
  Complete submission text file 0001477932-15-001225.txt   1778673

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctxr-20141231.xml EX-101.INS 162974
5 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20141231.xsd EX-101.SCH 24120
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20141231_cal.xml EX-101.CAL 28954
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20141231_def.xml EX-101.DEF 53031
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20141231_lab.xml EX-101.LAB 142638
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20141231_pre.xml EX-101.PRE 111944
Mailing Address 63 GREAT ROAD MAYNARD MA 01754
Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-170781 | Film No.: 15622853
SIC: 3714 Motor Vehicle Parts & Accessories